Trospium: Difference between revisions
Jump to navigation
Jump to search
imported>Joe Quick m (subpages) |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
Trospium chloride is an antispasmodic, antimuscarinic agent that is indicated for the treatment of overactive bladder. | '''Trospium''' chloride is an antispasmodic, antimuscarinic agent that is indicated for the treatment of overactive bladder. | ||
==Effectiveness== | ==Effectiveness== | ||
| Line 10: | Line 10: | ||
==See also== | ==See also== | ||
[http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=5413 FDA approved information] | [http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=5413 FDA approved information] | ||
[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 17:01, 30 October 2024
Trospium chloride is an antispasmodic, antimuscarinic agent that is indicated for the treatment of overactive bladder.
Effectiveness
A randomized controlled trial found that trospium is effective.[1]
References
- ↑ Staskin D, Sand P, Zinner N, Dmochowski R (2007). "Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial". J. Urol. 178 (3 Pt 1): 978–83; discussion 983–4. DOI:10.1016/j.juro.2007.05.058. PMID 17632131. Research Blogging.